FOXO4-DRI
Also known as FOXO4 D-retro-inverso peptide
Studied for: senescent-cell research
FOXO4-DRI is a synthetic D-retro-inverso peptide based on the p53-binding region of the transcription factor FOXO4, joined to a cell-penetrating sequence. Research examines it as a candidate senolytic, studied for selective effects on senescent cells in preclinical models of aging.
How it is thought to work
Research investigates FOXO4-DRI for competing with FOXO4 for binding to p53, studied for releasing p53 from the nucleus and triggering apoptosis selectively in senescent cells.
- FOXO4-p53 InterfaceStudied as a competitive binder that interrupts the interaction retaining p53 in senescent-cell nuclei.
- Selective ClearanceExplored in cell and mouse models for apoptosis in senescent cells while sparing healthy proliferating cells.
- D-Retro-Inverso DesignStudied for the protease resistance conferred by a reversed sequence built from D-amino acids.
- Route studied
- Subcutaneous
Studies
Cited research
Citations pending review. We add PubMed references once each one has been checked against the source.
Ask about FOXO4-DRI
Plain answers from our library: the science, the studied ranges and our products. It can be wrong, and it does not give medical advice.
AI answers can be wrong. Research use only.